Bristol-Myers Squibb

Top Companies in Pharm Country Ranked by Revenue
BioSpace
Fri, 02/7/20 - 11:46 pm
Connecticut
New York
New Jersey
Pennsylvania
Rhode Island
Merck
Bristol-Myers Squibb
Regeneron
Ipsen
Ovid Therapeutics
Codagenix
How Bristol-Myers Squibb Trounced Wall Street's Q4 Estimates
Motley Fool
Thu, 02/6/20 - 11:47 am
Bristol-Myers Squibb
earnings
Celgene
M&A
Factors Setting the Tone for Bristol-Myers (BMY) Q4 Earnings
Yahoo/Zacks.com
Tue, 02/4/20 - 10:24 am
Bristol-Myers Squibb
earnings
Bristol-Myers forms fibrotic disease biotech, bags buyout option
Fierce Biotech
Tue, 02/4/20 - 10:08 am
Bristol-Myers Squibb
BioMotiv
Anteros Pharmaceuticals
fibrotic disease
Bristol-Myers Withdraws European Application for Lung Cancer Combo
Motley Fool
Sun, 02/2/20 - 11:51 pm
Bristol-Myers Squibb
Europe
Opdivo
Yervoy
non-small cell lung cancer
Big pharma backed away from brain drugs. Is a return in sight?
BioPharma Dive
Wed, 01/29/20 - 11:55 pm
Big Pharma
Neuroscience
AstraZeneca
Bristol-Myers Squibb
GSK
Pfizer
Amgen
Celgene taps Bristol-Myers salesforce to bolster key blood cancer launches
Fierce Pharma
Wed, 01/15/20 - 11:13 pm
Celgene
Bristol-Myers Squibb
blood cancer
JPM Monday roundup: No deals, but drug-pricing startup causes the biggest noise
Fierce Biotech
Tue, 01/14/20 - 10:19 am
JPMHC 2020
M&A
Gilead Sciences
Bristol-Myers Squibb
JPM: Bristol chief says one-third of Celgene cost cuts will hit in 2020
Fierce Pharma
Mon, 01/13/20 - 11:43 pm
M&A
JPMHC 2020
Bristol-Myers Squibb
Celgene
Giovanni Caforio
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
Yahoo/Benzinga
Sat, 01/11/20 - 11:02 pm
JPMHC 2020
Bristol-Myers Squibb
Vertex Pharmaceuticals
Biomarin
Regeneron
Biogen
Alexion
Gilead Sciences
Amgen
Bristol-Myers confident of approvals linked to higher Celgene investor payout: Bristol executive
Reuters
Sat, 01/11/20 - 12:06 am
Bristol-Myers Squibb
Celgene
M&A
liso-cel
ozanimod
bb2121
FDA
B-MS, Sanofi Claim Hawaii is Violating Their Free Speech in Plavix Suit
RAPS.org
Thu, 01/9/20 - 11:50 pm
freedom of speech
Bristol-Myers Squibb
Sanofi
Hawaii
Plavix
A big finish confirms 2019 as a takeover year to remember
EP Vantage
Thu, 01/9/20 - 10:49 am
M&A
AbbVie
Allergan
Astellas
Bristol-Myers Squibb
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
US cancer death rate drops by sharpest rate on record
BioPharma Dive
Wed, 01/8/20 - 12:06 pm
cancer
Bristol-Myers Squibb
Yervoy
Merck
Keytruda
Bristol-Myers unloads old-school plant as it readies for CAR-T future
Fierce Pharma
Tue, 01/7/20 - 10:47 pm
Bristol-Myers Squibb
Celgene
CAR-T
M&A
Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto
Xconomy
Tue, 01/7/20 - 10:53 am
Amira Pharmaceuticals
Bristol-Myers Squibb
Celgene
PharmAkea
Galecto Biotech
fibrotic disease
Top Biopharma M&As in 2019
BioSpace
Fri, 01/3/20 - 10:06 am
M&A
Bristol-Myers Squibb
Celgene
AbbVie
Allergan
Roche
Spark Therapeutics
Novartis
The Medicines Company
Alkermes
Rodin Therapeutics
Sumitomo Dainippon
Roivant
Pfizer, BMS, Gilead, AbbVie and others hike prices on hundreds of meds to ring in 2020
Fierce Pharma
Thu, 01/2/20 - 10:46 am
drug pricing
Pfizer
Bristol-Myers Squibb
AbbVie
As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis
Endpoints
Thu, 12/26/19 - 01:18 pm
Pfizer
Bristol-Myers Squibb
FDA
generics
bloodthinners
Eliquis
Micro Labs
Mylan
How Gilead Sciences Is Helping Fund Bristol-Myers Squibb's Celgene Acquisition
Motley Fool
Sun, 12/22/19 - 12:32 am
Bristol-Myers Squibb
Celgene
M&A

Pages